Griffon Corporation (GFF)
Return on equity (ROE)
| Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | 209,897 | 189,371 | 197,490 | 71,092 | 77,617 | -381,180 | -290,098 | -162,154 | -191,558 | 241,166 | 117,586 | 69,009 | 79,211 | 83,410 | 88,534 | 72,317 | 53,429 | 49,433 | 41,197 | 39,146 |
| Total stockholders’ equity | US$ in thousands | 224,888 | 223,510 | 202,186 | 285,022 | 315,244 | 335,706 | 468,311 | 526,848 | 477,570 | 906,315 | 883,214 | 812,385 | 807,158 | 785,341 | 764,431 | 740,047 | 700,151 | 508,455 | 476,454 | 494,693 |
| ROE | 93.33% | 84.73% | 97.68% | 24.94% | 24.62% | -113.55% | -61.95% | -30.78% | -40.11% | 26.61% | 13.31% | 8.49% | 9.81% | 10.62% | 11.58% | 9.77% | 7.63% | 9.72% | 8.65% | 7.91% |
September 30, 2024 calculation
ROE = Net income (ttm) ÷ Total stockholders’ equity
= $209,897K ÷ $224,888K
= 93.33%
Griffon Corporation's return on equity (ROE) has exhibited significant fluctuations over the past few quarters. The ROE stood at 93.33% as of September 30, 2024, indicating a strong profitability relative to shareholders' equity. This represents an improvement from the previous quarter's ROE of 84.73%. However, the ROE has not been consistently high, as seen in previous periods with negative ROE figures such as -113.55% in June 2023 and -61.95% in March 2023.
The company's ROE reached its lowest level of -40.11% in September 2022 before steadily increasing in subsequent periods. This improvement in ROE indicates that Griffon Corporation has been effectively utilizing its equity to generate profits for shareholders. It is essential for investors to monitor the company's ROE trend over time to assess its financial health and efficiency in generating returns on shareholders' investments.